Bank Of New York Mellon Corp Haemonetics Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$72.75 - $90.6 $39.8 Million - $49.5 Million	546,804 New	546,804 $45.2 Billion
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $41.4 Million - $48.3 Million	560,216 New	560,216 $44.1 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $1.13 Million - $1.41 Million	17,929 Added 3.01%	614,235 $45.5 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $783,885 - $1.05 Million	-15,910 Reduced 2.6%	596,306 $38.9 Million
Q1 2022 May 11, 2022	BUY	$43.77 - $63.22 $1.15 Million - $1.66 Million	26,233 Added 4.48%	612,216 $38.7 Million
Q4 2021 Feb 11, 2022	BUY	$49.55 - $74.59 $305,624 - $460,071	6,168 Added 1.06%	585,983 $31.1 Million
Q3 2021 Nov 12, 2021	BUY	$57.6 - $70.59 $1.34 Million - $1.64 Million	23,237 Added 4.17%	579,815 $40.9 Million
Q2 2021 Aug 11, 2021	BUY	$51.81 - $118.56 $3.41 Million - $7.8 Million	65,794 Added 13.41%	556,578 $37.1 Million
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $626,873 - $787,643	-5,647 Reduced 1.14%	490,784 $54.5 Million
Q4 2020 Feb 09, 2021	SELL	$88.75 - $119.95 $271,486 - $366,927	-3,059 Reduced 0.61%	496,431 $59 Million
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $3.35 Million - $4.14 Million	-44,231 Reduced 8.13%	499,490 $43.6 Million
Q2 2020 Aug 12, 2020	SELL	$84.96 - $118.91 $4.06 Million - $5.68 Million	-47,736 Reduced 8.07%	543,721 $48.7 Million
Q1 2020 May 06, 2020	BUY	$74.34 - $121.82 $1.55 Million - $2.55 Million	20,910 Added 3.66%	591,457 $58.9 Million
Q4 2019 Feb 14, 2020	SELL	$114.37 - $129.46 $2.34 Million - $2.65 Million	-20,440 Reduced 3.46%	570,547 $65.6 Million
Q3 2019 Nov 07, 2019	SELL	$117.16 - $138.52 $5.67 Million - $6.7 Million	-48,374 Reduced 7.57%	590,987 $74.5 Million
Q2 2019 Aug 12, 2019	SELL	$81.74 - $120.34 $9.52 Million - $14 Million	-116,516 Reduced 15.41%	639,361 $76.9 Million
Q1 2019 May 14, 2019	SELL	$83.25 - $102.12 $5.55 Million - $6.81 Million	-66,669 Reduced 8.11%	755,877 $66.1 Million
Q4 2018 Feb 11, 2019	SELL	$90.66 - $116.63 $2.92 Million - $3.76 Million	-32,229 Reduced 3.77%	822,546 $82.3 Million
Q3 2018 Nov 09, 2018	BUY	$89.96 - $114.58 $6.22 Million - $7.92 Million	69,094 Added 8.79%	854,775 $0
Q2 2018 Aug 06, 2018	BUY	$71.53 - $95.75 $8.74 Million - $11.7 Million	122,168 Added 18.41%	785,681 $70.5 Million
Q1 2018 May 15, 2018	SELL	$60.72 - $74.41 $88,104 - $107,968	-1,451 Reduced 0.22%	663,513 $48.5 Million
Q4 2017 Feb 09, 2018	BUY	$44.96 - $58.99 $29.9 Million - $39.2 Million	664,964	664,964 $38.6 Million

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$448 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$389 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$334 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$316 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$303 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.86B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account